Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver disorders.
from Deals and IPOs https://ift.tt/2TjsLHx
No comments:
Post a Comment